ONESCREEN 5 Panel Cup w/ AD

As Low As $3.15 each Introducing The New 5 Panel OneScreen Drug Screen Cup Tests for: THC/COC/OPI-300/MAMP/AMP w/ pH,spec. gravity, & oxidants. All one needs to do is simply peel the label and view immediate results. FDA 510K & CLIA Waived. - Introducing The New 5 Panel Onescreen Drug Screen Cup (THC-MARIJUANA/OPI-300-OPIATES/COC-COCAINE/MAMP-METHAMPHETAMINE/AMP-AMPHETAMINE. All the administrator need to do is simply peel the label and view the testing results in the minutes following the urine collection! Excellent Design Patent-pending multiple drug screening cup Simple procedure with no addiltional steps required to activate test Screw lid for non-leakage Automatic split-specimen with no urine combination Test format from 3-12 drugs per cup Automatic split-specimen with no urine contamination Customized configurations available Reliable Results Easy-to-read result displayed in strong color code Long-lasting results stable for up to 1 hour 99% accuracy proved by clinical trials 18-24 month shelf life Set to SAMHSA Level cutoffs FDA Approved Test Formats: 5,6,8,10,&12 panel drug test cups with or without adulterants Tests Configurations: AMP, AMP 300 BAR BZO BUP COC, COC 150 MAMP, MAMP 500 MDMA MTD OPI 2000, OPI 300 OXY PCP PPX THC TCA FDA 510K & CLIA Waived CPT Code: G0430-QW - Drug screen, qualitative; multiple drug classes other than chromatographic method, each procedure - avg reimbursement $20.83 CPT Code: 80101-QW - Drug screen, qualitative; multiple drug classes other than chromatographic method, each procedure - avg reimbursement $20.83 NOTE: Its is always the healthcare provider's responsibility to establish reimbursement amount. Drug Name Abbreviation Cutoff Miminum Maximum Amphetamine AMP 300ng/ml 2-7 hours 2-4 days *Amphetamine AMP 1000ng/ml 2-7 hours 2-4 days Barbiturates BAR 300ng/ml 2-4 hours 1-3 weeks Benzodiazepines BZO 300ng/ml 2-7 hours 1-4 days Buprenorphine BUP 10ng/ml 2-7 hours 2-3 days Cocaine COC 150ng/ml 1-4 hours 2-4 days *Cocaine COC 300ng/ml 1-4 hours 2-4 days Ecstasy MDMA 500ng/ml 2-7 hours 2-4 days Marijuana THC 20ng/ml 2 hours up to 40 days *Marijuana THC 50ng/ml 2 hours up to 40 days Methadone MTD 300ng/ml 3-8 hours 1-3 days Methamphetamine mAMP 500ng/ml 2-7 hours 2-4 days *Methamphetamine mAMP 1000ng/ml 2-7 hours 2-4 days *Morphine MOP 300ng/ml 2 hours 2-3 days Opiates OPI 2000ng/ml 2 hours 2-3 days Oxycodone OXY 100ng/ml 1-3 hours 1-2 days Phencyclidine PCP 25ng/ml 4-6 hours 7-14 days Tricyclic Antidepressants TCA 1000ng/ml 8-12 hours 2-7 days Propoxyphene PPX 300ng/ml 2-7 hours 2-3 days *These drugs are present on this test panel
American Screening Corporation
HACKER SAFE certified sites prevent over 99.9% of hacker crime.
GSA Advantage Toll Free  (866) 526-2873
sales@americanscreeningcorp.com
Phone (318) 798-3306   .   Fax (318) 798-3386
Training Drug Search Contact Us
  Directory  |  My Account  |  Affiliate Signup  |  Catalog Request  
Product Search
All Products Page
What's Hot

Go Daddy
Credit Cards
PO & Money orders Accepted.
Click to verify BBB accreditation and to see a BBB report.
Top > Products > NEW Categories > Drug Testing- Cups > ONESCREEN Multi-Drug > ONESCREEN 5 Panel Cup w/ AD

ONESCREEN 5 Panel Cup w/ AD

Product 0 of 12   Next >>
5 panel onescreen cup with adulterants

Choose Options
Quantity:

ONESCREEN 5 Panel Cup w/ AD Description

Introducing The New 5 Panel Onescreen Drug Screen Cup (THC-MARIJUANA/OPI-300-OPIATES/COC-COCAINE/MAMP-METHAMPHETAMINE/AMP-AMPHETAMINE. All the administrator need to
do is simply peel the label and view the testing results in the minutes following the urine collection!

Excellent Design

  • Patent-pending multiple drug screening cup
  • Simple procedure with no addiltional steps required to activate test
  • Screw lid for non-leakage
  • Automatic split-specimen with no urine combination
  • Test format from 3-12 drugs per cup
  • Automatic split-specimen with no urine contamination
  • Customized configurations available

Reliable Results

  • Easy-to-read result displayed in strong color code
  • Long-lasting results stable for up to 1 hour
  • 99% accuracy proved by clinical trials
  • 18-24 month shelf life
  • Set to SAMHSA Level cutoffs
  • FDA Approved

Test Formats: 5,6,8,10,&12 panel drug test cups with or without adulterants

Tests Configurations:

  • AMP, AMP 300
  • BAR
  • BZO
  • BUP
  • COC, COC 150
  • MAMP, MAMP 500
  • MDMA
  • MTD
  • OPI 2000, OPI 300
  • OXY
  • PCP
  • PPX
  • THC
  • TCA

FDA 510K & CLIA Waived

CPT Code: G0430-QW - Drug screen, qualitative; multiple drug classes other than chromatographic method, each procedure - avg reimbursement $20.83

CPT Code: 80101-QW - Drug screen, qualitative; multiple drug classes other than chromatographic method, each procedure - avg reimbursement $20.83

NOTE: Its is always the healthcare provider's responsibility to establish reimbursement amount.

Drug Name

Abbreviation

Cutoff

Miminum

Maximum

Amphetamine AMP 300ng/ml 2-7 hours 2-4 days
*Amphetamine AMP 1000ng/ml 2-7 hours 2-4 days
Barbiturates BAR 300ng/ml 2-4 hours 1-3 weeks
Benzodiazepines BZO 300ng/ml 2-7 hours 1-4 days
Buprenorphine BUP 10ng/ml 2-7 hours 2-3 days
Cocaine COC 150ng/ml 1-4 hours 2-4 days
*Cocaine COC 300ng/ml 1-4 hours 2-4 days
Ecstasy MDMA 500ng/ml 2-7 hours 2-4 days
Marijuana THC 20ng/ml 2 hours up to 40 days
*Marijuana THC 50ng/ml 2 hours up to 40 days
Methadone MTD 300ng/ml 3-8 hours 1-3 days
Methamphetamine mAMP 500ng/ml 2-7 hours 2-4 days
*Methamphetamine mAMP 1000ng/ml 2-7 hours 2-4 days
*Morphine MOP 300ng/ml 2 hours 2-3 days
Opiates OPI 2000ng/ml 2 hours 2-3 days
Oxycodone OXY 100ng/ml 1-3 hours 1-2 days
Phencyclidine PCP 25ng/ml 4-6 hours 7-14 days
Tricyclic Antidepressants TCA 1000ng/ml 8-12 hours 2-7 days
Propoxyphene PPX 300ng/ml 2-7 hours 2-3 days

*These drugs are present on this test panel

ASC Newsletter

Enter your e-mail address to subscribe.
Testimonials
View Cart


Learn More >>


Learn More >>


Learn More >>


Learn More >>


Learn More >>



© Copyright, American Screening Corporation, 2008 Privacy Policy  |  Shipping Policy  |  Return Policy  |  Disclaimer